Cita APA

Tovar, V., Cornella, H., Moeini, A., Vidal, S., Hoshida, Y., Sia, D., . . . Llovet i Bayer, J. M. (2017). Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma.

Citación estilo Chicago

Tovar, Victoria, et al. Tumour Initiating Cells and IGF/FGF Signalling Contribute to Sorafenib Resistance in Hepatocellular Carcinoma. 2017.

Cita MLA

Tovar, Victoria, et al. Tumour Initiating Cells and IGF/FGF Signalling Contribute to Sorafenib Resistance in Hepatocellular Carcinoma. 2017.